Blood-Based Surveillance Monitoring of Circulating Tumor DNA From Patients With SCLC Detects Disease Relapse and Predicts Death in Patients With Limited-Stage Disease by Iams, Wade T., MD, Kopparapu, Prasad R., PhD, Yan, Yingjun, MS, Muterspaugh, Anel, MPH, Zhao, Zhiguo, MS, Chen, Heidi, PhD, Cann, Christopher, MD, York, Sally, MD, PhD, Horn, Leora, MD, MS, Ancell, Kristin, MD, Wyman, Kenneth, MD, Bertucci, Caterina, MPA, Shaffer, Tristan, MS, Hodsdon, Lauren A., MPH, Garg, Kavita, PhD, Hosseini, Seyed Ali, MD, PhD, Lim, Lee P., PhD, Lovly, Christine M., MD, PhD

Get full text